VTRS — Viatris Inc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1792044 ·
Last close
$20.45
Market Cap
$23.45B
52W High
$21.20
52W Low
$9.80
ADV30
9,643,446
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 3,749,500,000 | 1,438,000,000 | 255,500,000 | -325,300,000 | 34,682,600,000 | 1,789,200,000 | 20,997,100,000 |
| Jun 2026 | 3,756,800,000 | 1,456,500,000 | 73,700,000 | -118,800,000 | 35,044,600,000 | 886,500,000 | 20,784,200,000 |
| Mar 2026 | 3,517,000,000 | 1,157,200,000 | -20,200,000 | 176,400,000 | 36,834,600,000 | 1,804,200,000 | 22,176,900,000 |
| Dec 2025 | 3,703,600,000 | 1,147,900,000 | -157,500,000 | -340,100,000 | 37,193,100,000 | 1,322,400,000 | 22,481,800,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,485,300,000
Investing CF
$306,900,000
Financing CF
$-1,972,600,000
CapEx
$-507,500,000
Dividends Paid
$-555,100,000
Buybacks
$-385,100,000
EPS Diluted TTM
$-0.53
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-656,000,000
Inventory
$3,829,200,000
Receivables
$3,420,100,000
ST Investments
$217,100,000
EBIT TTM
$-53,600,000
Pretax Income TTM
$-526,400,000
Interest Exp TTM
$472,800,000
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$14,726,899,712
EBITDA
$4,376,399,872
Free Cash Flow
$3,158,449,920
Enterprise Value
$34,398,912,512
Total Cash
$2,006,300,032
Total Debt
$13,579,299,840
Shares Out
1,146,454,729
Trailing EPS
$-0.53
Book Value
$11.94
ROE
-4.2%
ROA
2.9%
Div Yield
2.41%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 14,299,900,000 | 253,500,000 | -3,514,900,000 | 37,193,100,000 | 22,481,800,000 | 14,711,300,000 | 2,315,900,000 |
| Dec 2024 | 14,739,300,000 | 710,300,000 | -634,200,000 | 41,500,900,000 | 22,865,400,000 | 18,635,500,000 | 2,302,900,000 |
| Dec 2023 | 15,426,900,000 | 1,563,400,000 | 54,700,000 | 47,685,500,000 | 27,218,100,000 | 20,467,400,000 | 2,900,000,000 |
| Dec 2022 | 16,262,700,000 | 1,655,700,000 | 2,078,600,000 | 50,022,200,000 | 28,949,900,000 | 21,072,300,000 | 2,999,000,000 |
TTM Snapshot
Revenues TTM
$14,737,300,000
NetIncome TTM
$-410,700,000
OpCashFlow TTM
—
Assets (Latest)
$35,044,600,000
Forward EPS
$2.75
Max Pain — expiry 2027-01-15
max pain strike: $10.00 · spot: $19.86 · call oi: 45,251 · put oi: 12,631
Expected Move to 2027-01-15:
±$2.05
(10.32%) —
implied range
$17.81 –
$21.91
· ATM straddle on $20.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | $24.88B | $584.10 | — |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | $20.96B | $156.50 | — |
| INSM | INSMED Inc | $26.73B | $121.86 | — |
| ROIV | Roivant Sciences Ltd. | $28.05B | $38.71 | — |
| RPRX | Royalty Pharma plc | $30.58B | $68.68 | — |
News headlines (Yahoo Finance, 1h cache)
Viatris Completes Acquisition of Pacira BioSciences
2026-11-17 13:50 · Yahoo
Are Investors Undervaluing Viatris (VTRS) Right Now?
2026-11-17 13:40 · Yahoo
CADILLAC FORMULA 1® TEAM WELCOMES VIATRIS AS OFFICIAL GLOBAL PHARMACEUTICAL PARTNER
2026-11-16 14:00 · Yahoo
Viatris to Participate in Upcoming Investor Conferences
2026-11-11 11:59 · Yahoo
VTRS or DHR: Which Is the Better Value Stock Right Now?
2026-11-10 19:38 · Yahoo
Viatris Inc. (VTRS) Hit a 52 Week High, Can the Run Continue?
2026-11-10 13:15 · Yahoo
VTRS Q3 2026 deep dive: new product launches and Pacira acquisition shape outlook
2026-11-10 08:45 · Yahoo
Viatris (VTRS) Stock May Be Below Fair Value Despite A $1.65B Deal
2026-11-08 01:15 · Yahoo
Viatris (VTRS) Earnings Beat And Higher Outlook Put Fair Value Back In Focus
2026-11-07 09:17 · Yahoo
Are Wall Street Analysts Predicting Viatris Stock Will Climb or Sink?
2026-11-06 12:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.